Evidence map›Paper›PMID 28687211›Full record

ReviewInfectious disease clinics of North America2017

Preventing Transmission of Multidrug-Resistant Pathogens in the Intensive Care Unit.

Jeffrey R Strich, Tara N Palmore

Open access · greenAbstract readReview
In one paragraph

Review in Infectious disease clinics of North America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Multidrug-Resistant Sepsis: A Critical Healthcare Challenge.Antibiotics (Basel, Switzerland) · 2024
    Review
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Disinfection Strategies for Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  16. Article
  17. Monitoring Multidrug-ResistantPolish journal of microbiology · 2022
    Article
  18. Review
  19. Common microbial isolates in an adult intensive care unit before and after its relocation and expansion.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2022
    Article
  20. Critical illness in the returning traveller.Journal of the Intensive Care Society · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jeffrey R StrichCritical Care Medicine Department, National Institutes of Health Clinical Center, 10 Center Drive, MSC 1662, Bethesda, MD 20892-1662, USA.
Tara N PalmoreHospital Epidemiology Service, National Institutes of Health Clinical Center, 10 Center Drive, MSC 1899, Bethesda, MD 20892-1899, USA. Electronic address: tpalmore@mail.nih.gov.
National Institutes of Health Clinical Center · US

Funding

Intramural NIH HHS Z99 CL999999
6 · The paper itself

Abstract

Infection control in the intensive care unit (ICU) has seen many advances, including rapid molecular screening tests for resistant organisms and chlorhexidine use in daily baths. Although these developments advance the cause of infection prevention, compliance with some of the basic measures remains elusive. Hand hygiene, antimicrobial stewardship, and reduction in device use remain the low-technology interventions that could have a major impact on nosocomial transmission of antimicrobial-resistant organisms. Although continued research is needed on new and old ways of preventing nosocomial infections, ICU staff must persevere in improving adherence with the measures that are known to be effective.

Indexed as

Drug Resistance, Multiple, BacterialAntimicrobial StewardshipBacterial InfectionsChlorhexidineCross InfectionHand HygieneHumansInfection ControlIntensive Care UnitsUnited StatesChlorhexidineDrug resistanceInfection controlIntensive care unitTransmission

Identifiers

PMID28687211
PMCPMC5584576
OpenAlexW2731541034

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.